A Cav3.2 and Cav3.3 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ML-218

Item No. 43541

Technical Information
Formal Name
3,5-dichloro-N-[[(1α,5α,6α)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide
CAS Number
1346233-68-8
Molecular Formula
C19H26Cl2N2O
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Slightly soluble: 0.1-1 mg/mlEthanol: Sparingly soluble: 1-10 mg/ml
SMILES
[H][C@]12CN(C[C@@]([C@@H]2CNC(C3=CC(Cl)=CC(Cl)=C3)=O)1[H])CCC(C)(C)C
InChi Code
InChI=1S/C19H26Cl2N2O/c1-19(2,3)4-5-23-10-16-15(17(16)11-23)9-22-18(24)12-6-13(20)8-14(21)7-12/h6-8,15-17H,4-5,9-11H2,1-3H3,(H,22,24)/t15-,16-,17+
InChi Key
GSJIGYLGKSBYBC-OSYLJGHBSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ML-218 is an inhibitor of T-type voltage-gated calcium channel 3.2 (Cav3.2) and Cav3.3.1 It inhibits currents in whole-cell patch clamp assays using HEK293 cells expressing Cav3.2 or Cav3.3 (IC50s = 310 and 274 nM, respectively). ML-218 (0.1-30 mg/kg) decreases the latency to paw withdrawal in a rat model of catalepsy induced by haloperidol (Item No. 12014).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Xiang, Z., Thompson, A.D., Brogan, J.T., et alThe discovery and characterization of ML218: A novel, centrally active T-type calcium channel inhibitor with robust effects in STN neurons and in a rodent model of Parkinson’s Disease. ACS Chem. Neurosci. 2(12), 730-742 (2011).